List of works - Avy Violari

A child with perinatal HIV infection and long-term sustained virological control following antiretroviral treatment cessation

scientific article published in Nature Communications

A prospective study of the immune reconstitution inflammatory syndrome (IRIS) in HIV-infected children from high prevalence countries

scientific article published on 01 July 2019

A randomized trial of two postexposure prophylaxis regimens to reduce mother-to-child HIV-1 transmission in infants of untreated mothers

scientific article published on August 2005

A retrospective case-cohort study comparing treatment outcomes in abacavir versus stavudine containing first line antiretroviral treatment regimens in children <3yrs old, at a paediatric programme based in Soweto, South Africa.

scientific article

Active tuberculosis case-finding among pregnant women presenting to antenatal clinics in Soweto, South Africa

scientific article

African Multi-Site 2-Year Neuropsychological Study of School-Age Children Perinatally Infected, Exposed, and Unexposed to Human Immunodeficiency Virus

scientific article published on 18 December 2019

Antiretroviral treatment for children with peripartum nevirapine exposure

scientific article

Association of pol diversity with antiretroviral treatment outcomes among HIV-infected African children

scientific article

Behavioral Functioning and Quality of Life in South African Children Living with HIV on Antiretroviral Therapy

scientific article published on 23 July 2020

Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention

scientific article

Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention

article

Biomarkers of Aging in HIV-Infected Children on Suppressive Antiretroviral Therapy

scientific article published on 01 August 2018

Childhood adversity increases the risk of onward transmission from perinatal HIV-infected adolescents and youth in South Africa

scientific article published on 8 February 2018

Combining PMTCT with active case finding for tuberculosis.

scientific article

Correction: Association of Diversity with Antiretroviral Treatment Outcomes among HIV-Infected African Children

scientific article published on 11 December 2013

Correction: Association of pol Diversity with Antiretroviral Treatment Outcomes among HIV-Infected African Children.

scientific article published on 23 December 2013

Distinct epigenetic profiles in children with perinatally-acquired HIV on antiretroviral therapy

scientific article published on 19 July 2019

Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial

scientific article published in 2022

Early ART Results in Greater Immune Reconstitution Benefits in HIV-Infected Infants: Working with Data Missingness in a Longitudinal Dataset

scientific article (publication date: 2015)

Early Antiretroviral Therapy and Mortality among HIV-Infected Infants

scientific article

Early Antiretroviral Therapy reduces the incidence of otorrhea in a randomized study of early and deferred antiretroviral therapy: Evidence from the Children with HIV Early Antiretroviral Therapy (CHER) Study

scientific article

Early antiretroviral therapy improves neurodevelopmental outcomes in infants

scientific article

Early severe HIV disease precedes early antiretroviral therapy in infants: Are we too late?

scientific article

Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial

scientific article

Educational delays among children living with perinatally-acquired HIV in Johannesburg, South Africa

scientific article published on 09 July 2019

Effect of HIV exposure and timing of antiretroviral therapy initiation on immune memory responses to diphtheria, tetanus, whole cell pertussis and hepatitis B vaccines

article

Effect of HIV-1 exposure and antiretroviral treatment strategies in HIV-infected children on immunogenicity of vaccines during infancy

scientific article published on February 2014

Effect of HIV-exposure and timing of antiretroviral treatment initiation in children living with HIV on antibody persistence and memory responses to Haemophilus influenzae type b and pneumococcal polysaccharide-protein conjugate vaccines

scientific article published on 15 February 2020

Effect of in-utero HIV exposure and antiretroviral treatment strategies on measles susceptibility and immunogenicity of measles vaccine

scientific article published on June 2013

Efficacy and immunogenicity of influenza vaccine in HIV-infected children: a randomized, double-blind, placebo controlled trial

scientific article published in January 2013

Extent of disclosure: what perinatally HIV-infected children have been told about their own HIV status

scientific article published on 29 August 2016

Five year neurodevelopment outcomes of perinatally HIV-infected children on early limited or deferred continuous antiretroviral therapy. ⬇️

scientific article published in May 2018

Gamma interferon production in response to Mycobacterium bovis BCG and Mycobacterium tuberculosis antigens in infants born to human immunodeficiency virus-infected mothers

scientific article

Genotypic and phenotypic characterization of viral isolates from HIV-1 subtype C-infected children with slow and rapid disease progression

scientific article published in May 2006

Growing up positive: adolescent HIV disclosure to sexual partners and others

scientific article published on 03 March 2020

Immunogenicity of 13-valent pneumococcal conjugate vaccine among children with underlying medical conditions

scientific article published on 5 July 2017

Impact of HIV and Atiretroviral Therapy on Neurocognitive Outcomes Among School-Aged Children

scientific article published on 6 February 2017

Implementation of a PMTCT programme in a high HIV prevalence setting in Johannesburg, South Africa: 2002-2015

scientific article published on 23 March 2020

Increased microbial translocation in ≤ 180 days old perinatally human immunodeficiency virus-positive infants as compared with human immunodeficiency virus-exposed uninfected infants of similar age.

scientific article

Inferior quantitative and qualitative immune responses to pneumococcal conjugate vaccine in infants with nasopharyngeal colonization by Streptococcus pneumoniae during the primary series of immunization

scientific article

Influenza Vaccination of Pregnant Women and Protection of Their Infants

Influenza vaccination of pregnant women and protection of their infants

scientific article

Isoniazid Preventive Therapy in HIV-Infected Pregnant and Postpartum Women

scientific article published on 01 October 2019

Low Vitamin-D Levels Combined with PKP3-SIGIRR-TMEM16J Host Variants Is Associated with Tuberculosis and Death in HIV-Infected and -Exposed Infants

scientific article published on 12 February 2016

Maternal health outcomes among HIV-infected breastfeeding women with high CD4 counts: results of a treatment strategy trial

article

Measles Immunity at 4.5 Years of Age Following Vaccination at 9 and 15–18 Months of Age Among Human Immunodeficiency Virus (HIV)–infected, HIV-exposed–uninfected, and HIV-unexposed Children

article

Mental Health of Adolescents in the Era of Antiretroviral Therapy: Is There a Difference Between HIV-Infected and Uninfected Youth in South Africa?

scientific article published on 05 April 2020

Mitochondrial Impairment in Well-Suppressed Children with Perinatal HIV-Infection on Antiretroviral Therapy

scientific article published on 15 July 2019

Naïve B-cell output in HIV-infected and HIV-uninfected children

article

Negative Diagnostic PCR Tests in School-Aged, HIV-Infected Children on Antiretroviral Therapy Since Early Life in Johannesburg, South Africa

scientific article published on 01 April 2020

Neuropsychological performance in African children with HIV enrolled in a multisite antiretroviral clinical trial.

scientific article published on 2 November 2017

Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children

scientific article

Nevirapine- Versus Lopinavir/Ritonavir-Based Antiretroviral Therapy in HIV-Infected Infants and Young Children: Long-term Follow-up of the IMPAACT P1060 Randomized Trial.

scientific article published on 20 July 2016

Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial

scientific article published in 2022

Optimizing Clinical Trial Design to Maximize Evidence Generation in Pediatric HIV

article

Patterns of Growth, Body Composition, and Lipid Profiles in a South African Cohort of Human Immunodeficiency Virus-Infected and Uninfected Children: A Cross-Sectional Study

scientific article published on 6 May 2017

Pharmacokinetics and drug-drug interactions of isoniazid and efavirenz in pregnant women living with HIV in high TB incidence settings: importance of genotyping

scientific article published on 09 September 2020

Predictors of virologic and clinical response to nevirapine versus lopinavir/ritonavir-based antiretroviral therapy in young children with and without prior nevirapine exposure for the prevention of mother-to-child HIV transmission

scientific article

Pregnancy outcomes of women conceiving on antiretroviral therapy (ART) compared to those commenced on ART during pregnancy

scientific article published on 20 June 2020

Primary isoniazid prophylaxis against tuberculosis in HIV-exposed children

scientific article

Prospective cohort study comparing seasonal and H1N1(2009) pandemic influenza virus illnesses in HIV-infected children during 2009.

scientific article

Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial

scientific article published on 01 May 2020

Reactivity of routine HIV antibody tests in children who initiated antiretroviral therapy in early infancy as part of the Children with HIV Early Antiretroviral Therapy (CHER) trial: a retrospective analysis

scientific article published in June 2015

Recovery of HIV encephalopathy in perinatally infected children on antiretroviral therapy

scientific article published on 10 August 2020

Risk Factors for Adverse Birth Outcomes in the PROMISE 1077BF/1077FF Trial

scientific article published on 01 August 2019

Second- and Third-line Antiretroviral Therapy for Children and Adolescents: A Scoping Review

scientific article published on May 2017

Single Genome Analysis for the Detection of Linked Multiclass Drug Resistance Mutations in HIV-1-Infected Children After Failure of Protease Inhibitor-Based First-Line Therapy

scientific article

Streptococcus pneumoniae colonization in pneumococcal vaccine-naïve human immunodeficiency virus-exposed infected and -uninfected South African children

scientific article published on 01 February 2020

Support for relactation among mothers of HIV-infected children: a pilot study in Soweto

scientific article published on 4 September 2014

Temporal Changes in Pneumococcal Colonization in HIV-infected and HIV-uninfected Mother-Child Pairs Following Transitioning From 7-valent to 13-valent Pneumococcal Conjugate Vaccine, Soweto, South Africa

scientific article published on 17 March 2015

The association between the ratio of monocytes:lymphocytes at age 3 months and risk of tuberculosis (TB) in the first two years of life

scientific article

The impact of short term Antiretroviral Therapy (ART) interruptions on longer term maternal health outcomes-A randomized clinical trial

scientific article published on 30 January 2020

Thymic Output and CD4 T-Cell Reconstitution in HIV-Infected Children on Early and Interrupted Antiretroviral Treatment: Evidence from the Children with HIV Early Antiretroviral Therapy Trial.

scientific article published on 20 September 2017

Use of Multiplex Quantitative PCR To Evaluate the Impact of Pneumococcal Conjugate Vaccine on Nasopharyngeal Pneumococcal Colonization in African Children.

scientific article published on 8 November 2017

Utility of clinical parameters to identify HIV infection in infants below ten weeks of age in South Africa: a prospective cohort study

scientific article

List of works by Avy Violari

A child with perinatal HIV infection and long-term sustained virological control following antiretroviral treatment cessation

A prospective study of the immune reconstitution inflammatory syndrome (IRIS) in HIV-infected children from high prevalence countries

A randomized trial of two postexposure prophylaxis regimens to reduce mother-to-child HIV-1 transmission in infants of untreated mothers

A retrospective case-cohort study comparing treatment outcomes in abacavir versus stavudine containing first line antiretroviral treatment regimens in children <3yrs old, at a paediatric programme based in Soweto, South Africa.

Active tuberculosis case-finding among pregnant women presenting to antenatal clinics in Soweto, South Africa

African Multi-Site 2-Year Neuropsychological Study of School-Age Children Perinatally Infected, Exposed, and Unexposed to Human Immunodeficiency Virus

Antiretroviral treatment for children with peripartum nevirapine exposure

Association of pol diversity with antiretroviral treatment outcomes among HIV-infected African children

Behavioral Functioning and Quality of Life in South African Children Living with HIV on Antiretroviral Therapy

Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention

Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention

Biomarkers of Aging in HIV-Infected Children on Suppressive Antiretroviral Therapy

Childhood adversity increases the risk of onward transmission from perinatal HIV-infected adolescents and youth in South Africa

Combining PMTCT with active case finding for tuberculosis.

Correction: Association of Diversity with Antiretroviral Treatment Outcomes among HIV-Infected African Children

Correction: Association of pol Diversity with Antiretroviral Treatment Outcomes among HIV-Infected African Children.

Distinct epigenetic profiles in children with perinatally-acquired HIV on antiretroviral therapy

Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial

Early ART Results in Greater Immune Reconstitution Benefits in HIV-Infected Infants: Working with Data Missingness in a Longitudinal Dataset

Early Antiretroviral Therapy and Mortality among HIV-Infected Infants

Early Antiretroviral Therapy reduces the incidence of otorrhea in a randomized study of early and deferred antiretroviral therapy: Evidence from the Children with HIV Early Antiretroviral Therapy (CHER) Study

Early antiretroviral therapy improves neurodevelopmental outcomes in infants

Early severe HIV disease precedes early antiretroviral therapy in infants: Are we too late?

Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial

Educational delays among children living with perinatally-acquired HIV in Johannesburg, South Africa

Effect of HIV exposure and timing of antiretroviral therapy initiation on immune memory responses to diphtheria, tetanus, whole cell pertussis and hepatitis B vaccines

Effect of HIV-1 exposure and antiretroviral treatment strategies in HIV-infected children on immunogenicity of vaccines during infancy

Effect of HIV-exposure and timing of antiretroviral treatment initiation in children living with HIV on antibody persistence and memory responses to Haemophilus influenzae type b and pneumococcal polysaccharide-protein conjugate vaccines

Effect of in-utero HIV exposure and antiretroviral treatment strategies on measles susceptibility and immunogenicity of measles vaccine

Efficacy and immunogenicity of influenza vaccine in HIV-infected children: a randomized, double-blind, placebo controlled trial

Extent of disclosure: what perinatally HIV-infected children have been told about their own HIV status

Five year neurodevelopment outcomes of perinatally HIV-infected children on early limited or deferred continuous antiretroviral therapy. ⬇️

Gamma interferon production in response to Mycobacterium bovis BCG and Mycobacterium tuberculosis antigens in infants born to human immunodeficiency virus-infected mothers

Genotypic and phenotypic characterization of viral isolates from HIV-1 subtype C-infected children with slow and rapid disease progression

Growing up positive: adolescent HIV disclosure to sexual partners and others

Immunogenicity of 13-valent pneumococcal conjugate vaccine among children with underlying medical conditions

Impact of HIV and Atiretroviral Therapy on Neurocognitive Outcomes Among School-Aged Children

Implementation of a PMTCT programme in a high HIV prevalence setting in Johannesburg, South Africa: 2002-2015

Increased microbial translocation in ≤ 180 days old perinatally human immunodeficiency virus-positive infants as compared with human immunodeficiency virus-exposed uninfected infants of similar age.

Inferior quantitative and qualitative immune responses to pneumococcal conjugate vaccine in infants with nasopharyngeal colonization by Streptococcus pneumoniae during the primary series of immunization

Influenza Vaccination of Pregnant Women and Protection of Their Infants

Influenza vaccination of pregnant women and protection of their infants

Isoniazid Preventive Therapy in HIV-Infected Pregnant and Postpartum Women

Low Vitamin-D Levels Combined with PKP3-SIGIRR-TMEM16J Host Variants Is Associated with Tuberculosis and Death in HIV-Infected and -Exposed Infants

Maternal health outcomes among HIV-infected breastfeeding women with high CD4 counts: results of a treatment strategy trial

Measles Immunity at 4.5 Years of Age Following Vaccination at 9 and 15–18 Months of Age Among Human Immunodeficiency Virus (HIV)–infected, HIV-exposed–uninfected, and HIV-unexposed Children

Mental Health of Adolescents in the Era of Antiretroviral Therapy: Is There a Difference Between HIV-Infected and Uninfected Youth in South Africa?

Mitochondrial Impairment in Well-Suppressed Children with Perinatal HIV-Infection on Antiretroviral Therapy

Naïve B-cell output in HIV-infected and HIV-uninfected children

Negative Diagnostic PCR Tests in School-Aged, HIV-Infected Children on Antiretroviral Therapy Since Early Life in Johannesburg, South Africa

Neuropsychological performance in African children with HIV enrolled in a multisite antiretroviral clinical trial.

Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children

Nevirapine- Versus Lopinavir/Ritonavir-Based Antiretroviral Therapy in HIV-Infected Infants and Young Children: Long-term Follow-up of the IMPAACT P1060 Randomized Trial.

Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial

Optimizing Clinical Trial Design to Maximize Evidence Generation in Pediatric HIV

Patterns of Growth, Body Composition, and Lipid Profiles in a South African Cohort of Human Immunodeficiency Virus-Infected and Uninfected Children: A Cross-Sectional Study

Pharmacokinetics and drug-drug interactions of isoniazid and efavirenz in pregnant women living with HIV in high TB incidence settings: importance of genotyping

Predictors of virologic and clinical response to nevirapine versus lopinavir/ritonavir-based antiretroviral therapy in young children with and without prior nevirapine exposure for the prevention of mother-to-child HIV transmission

Pregnancy outcomes of women conceiving on antiretroviral therapy (ART) compared to those commenced on ART during pregnancy

Primary isoniazid prophylaxis against tuberculosis in HIV-exposed children

Prospective cohort study comparing seasonal and H1N1(2009) pandemic influenza virus illnesses in HIV-infected children during 2009.

Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial

Reactivity of routine HIV antibody tests in children who initiated antiretroviral therapy in early infancy as part of the Children with HIV Early Antiretroviral Therapy (CHER) trial: a retrospective analysis

Recovery of HIV encephalopathy in perinatally infected children on antiretroviral therapy

Risk Factors for Adverse Birth Outcomes in the PROMISE 1077BF/1077FF Trial

Second- and Third-line Antiretroviral Therapy for Children and Adolescents: A Scoping Review

Single Genome Analysis for the Detection of Linked Multiclass Drug Resistance Mutations in HIV-1-Infected Children After Failure of Protease Inhibitor-Based First-Line Therapy

Streptococcus pneumoniae colonization in pneumococcal vaccine-naïve human immunodeficiency virus-exposed infected and -uninfected South African children

Support for relactation among mothers of HIV-infected children: a pilot study in Soweto

Temporal Changes in Pneumococcal Colonization in HIV-infected and HIV-uninfected Mother-Child Pairs Following Transitioning From 7-valent to 13-valent Pneumococcal Conjugate Vaccine, Soweto, South Africa

The association between the ratio of monocytes:lymphocytes at age 3 months and risk of tuberculosis (TB) in the first two years of life

The impact of short term Antiretroviral Therapy (ART) interruptions on longer term maternal health outcomes-A randomized clinical trial

Thymic Output and CD4 T-Cell Reconstitution in HIV-Infected Children on Early and Interrupted Antiretroviral Treatment: Evidence from the Children with HIV Early Antiretroviral Therapy Trial.

Use of Multiplex Quantitative PCR To Evaluate the Impact of Pneumococcal Conjugate Vaccine on Nasopharyngeal Pneumococcal Colonization in African Children.

Utility of clinical parameters to identify HIV infection in infants below ten weeks of age in South Africa: a prospective cohort study